These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 20947707)

  • 41. Chemotherapy-induced nausea and vomiting: current and new standards in the antiemetic prophylaxis and treatment.
    Jordan K; Kasper C; Schmoll HJ
    Eur J Cancer; 2005 Jan; 41(2):199-205. PubMed ID: 15661543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy.
    Jones JM; Qin R; Bardia A; Linquist B; Wolf S; Loprinzi CL
    J Palliat Med; 2011 Jul; 14(7):810-4. PubMed ID: 21554125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fixed Combination Antiemetic: A Literature Review on Prevention of Chemotherapy-Induced Nausea and Vomiting Using Netupitant/Palonosetron.
    Clark-Snow RA; Vidall C; Börjeson S; Jahn P
    Clin J Oncol Nurs; 2018 Apr; 22(2):E52-E63. PubMed ID: 29547597
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV): content and implementation in daily routine practice.
    Jordan K; Gralla R; Jahn F; Molassiotis A
    Eur J Pharmacol; 2014 Jan; 722():197-202. PubMed ID: 24157984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevention and control of chemotherapy-induced nausea and vomiting].
    Gómez-Raposo C; Feliú-Batlle J; González-Baróna M
    Med Clin (Barc); 2006 Feb; 126(4):143-51. PubMed ID: 16472500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Addressing the value of novel therapies in chemotherapy-induced nausea and vomiting.
    Schwartzberg L
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):825-34. PubMed ID: 25227565
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chemotherapy-induced nausea and vomiting: an overview and comparison of three consensus guidelines.
    Tageja N; Groninger H
    Postgrad Med J; 2016 Jan; 92(1083):34-40. PubMed ID: 26561590
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of Chemotherapy-Induced Nausea and Vomiting in Cancer Patients.
    Shankar A; Roy S; Malik A; Julka PK; Rath GK
    Asian Pac J Cancer Prev; 2015; 16(15):6207-13. PubMed ID: 26434818
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Practical management of chemotherapy-induced nausea and vomiting.
    Wiser W; Berger A
    Oncology (Williston Park); 2005 Apr; 19(5):637-45. PubMed ID: 15945344
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug insight: New antiemetics in the management of chemotherapy-induced nausea and vomiting.
    Oo TH; Hesketh PJ
    Nat Clin Pract Oncol; 2005 Apr; 2(4):196-201. PubMed ID: 16264934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer and chemotherapy-induced nausea and vomiting: a focus on olanzapine.
    Bosnjak SM; Dimitrijevic J; Djordjevic F
    Curr Opin Support Palliat Care; 2016 Jun; 10(2):180-8. PubMed ID: 27028050
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Assessment of chemotherapy-induced nausea and vomiting(CINV)using MASCC antiemesis tool].
    Yamaguchi M; Ogawa T; Watanabe M; Anami S; Kamigaki S; Nishikawa N; Ono T; Furukawa H
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1691-6. PubMed ID: 19838029
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Budget impact of netupitant/palonosetron for the prevention of chemotherapy-induced nausea and vomiting.
    Park SH; Binder G; Corman S; Botteman M
    J Med Econ; 2019 Aug; 22(8):840-847. PubMed ID: 31094589
    [No Abstract]   [Full Text] [Related]  

  • 54. Chemotherapy-induced nausea and vomiting (CINV) in 190 colorectal cancer patients: a prospective registration study by the CINV study group of Japan.
    Tsuji Y; Baba H; Takeda K; Kobayashi M; Oki E; Gotoh M; Yoshida K; Shimokawa M; Kakeji Y; Aiba K
    Expert Opin Pharmacother; 2017 Jun; 18(8):753-758. PubMed ID: 28395603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Options for the prevention and management of acute chemotherapy-induced nausea and vomiting in children.
    Dupuis LL; Nathan PC
    Paediatr Drugs; 2003; 5(9):597-613. PubMed ID: 12956617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of acupuncture in the control of chemotherapy-induced nausea and vomiting.
    Bao T
    J Natl Compr Canc Netw; 2009 May; 7(5):606-12. PubMed ID: 19460284
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy, safety and feasibility of fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in pediatric patients receiving moderately and highly emetogenic chemotherapy - results of a non-interventional observation study.
    Willier S; Cabanillas Stanchi KM; von Have M; Binder V; Blaeschke F; Feucht J; Feuchtinger T; Döring M
    BMC Cancer; 2019 Nov; 19(1):1118. PubMed ID: 31730451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Prophylaxis of chemotherapy-induced vomiting and nausea].
    Tóth J; Szántó J
    Magy Onkol; 2008 Dec; 52(4):391-4. PubMed ID: 19068468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antiemetic activity of corticosteroids in patients receiving cancer chemotherapy: dosing, efficacy, and tolerability analysis.
    Grunberg SM
    Ann Oncol; 2007 Feb; 18(2):233-40. PubMed ID: 17108149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Chemotherapy induced-vomiting--a practical guide for prevention and therapy].
    Jordan K; Voigt W; Schmoll HJ
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1869-72. PubMed ID: 16915549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.